May 15, 1996

Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers

Cancer Letters
M A NelsonN C Clements

Abstract

Oncogene and tumor suppressor gene mutations are candidate biomarkers for cancer risk assessment and lesion detection. The K-ras oncogene has previously been associated with non-small cell lung cancer (NSCLC), particularly adenocarcinomas in which reported rates of mutation have approached 30-40%. We have analyzed non-malignant lung tissue from patients with lung cancer and primary lung cancers for K-ras gene mutations. Mutations were detected in 32% cancers and 29% non-malignant lung tissue from patients with cancer. The majority of tumors testing positive were adenocarcinoma of the lung. Normal DNA controls, including peripheral blood lymphocytes and normal lung from non-smokers, were negative. The ability to detect genetic alterations in non-malignant lung tissues is consistent with the concept that genetic alterations are involved in field cancerization of the aerodigestive tract.

  • References18
  • Citations33

References

  • References18
  • Citations33

Citations

Mentioned in this Paper

HRAS
Adenocarcinoma of Lung (Disorder)
TNM Staging System
Lung
Peripheral Blood
Lymphocytes as Percentage of Blood Leukocytes (Lab Test)
Non-Small Cell Lung Cancer Pathway
Neoplasms
Non-Small Cell Lung Carcinoma
v-Ki-ras Genes

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
F M ScottJ L Mulshine
Seminars in Respiratory and Critical Care Medicine
Brigitte N GompertsSteven M Dubinett
© 2020 Meta ULC. All rights reserved